Vivo Bio Tech Ltd submits a nil report on physical share transfer re-lodgement requests for March 2026.
The report is filed in compliance with SEBI circular HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026.
Registrar Aarthi Consultants confirmed zero requests received, processed, approved, or rejected.
The filing serves as a regulatory disclosure to BSE regarding shareholder transfer activity.